PathAI leverages artificial intelligence and machine learning to transform pathology diagnosis and drug development. The platform uses advanced deep learning models to analyze tissue samples with superhuman accuracy, helping pathologists detect cancer, predict treatment responses, and accelerate clinical trials. Features include automated cancer detection, biomarker quantification, treatment prediction algorithms, and integration with existing pathology workflows. PathAI has partnerships with major pharmaceutical companies and healthcare institutions worldwide, processing millions of pathology images to improve patient outcomes through precision medicine.
